International Conference on Obstetricians, Gynecologists and Reproductive Biology
Allied Academies invites all the participants from all over the world to attend “International Obstetricians and Gynecologists and Reproductive Biology” held at LAS VEGAS, USA on OCTOBER 5TH – 6TH , 2017 which includes prompt Keynote Presentations, Special Sessions, Workshops, Symposiums, Oral talks, Poster Presentations and Exhibitions.
Theme: Caring for women at every stage of their lives
Obstetricians & Gynecologists 2017 offers a cutting edge program of renowned international speakers and specialists, concurrent sessions, oral and poster presentations attracting over200 experts in fertility, assisted conception, sexual health and reproductive biology and gynecology field. This conference has been carefully designed to meet the unique educational needs of Gynecologists.Obstetricians & Gynecologists 2017 has been made in an interdisciplinary manner with various tracks to choose from every segment and provides you a unique opportunity to meet up with peers from both industry and academia and establish a scientific network among. We cordially invite to join us at our event and make it successful by your participation.
A comprehensive range of topics will be discussed in the event including maternal fetal medicine, gynecology oncology, Sexual medicine, Substance Use & abuse, ultrasound diagnosis, Menstruation, leukoaraiosis, Endometriosis, Body Mass Index, genitourinary medicine, and Gynecologic Cancers. It is our ideology to bring maximum exposure to our attendees, so we make sure the event is a blend which covers professionals such as gynecologists, obstetricians, veteran researchers, Women healthcare professionals from academia and industry making the conference a perfect platform.
Allied Academies was founded by Jim and JoAnn Carland and the headquarters is located in North Carolina in United States of America. It conducts several academic conferences each year in different locations with internet participation possibilities for those who are physically unable to attend the conferences. Conference registrants are eligible for the Accelerated Journal Review. To provide you with maximum outlets for your research, Allied Business Academies holds joint meetings of all its member academies. In 1994 they launched the Journal of the International Academy of Case Studies, which has become a leader in publishing classroom teaching cases in business.
Why to attend???
With members from around the world focused on learning about Women’s Health and its advances, this is your best opportunity to reach the largest assemblage of participants from the Women’s Health community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new discoveries in the breast cancer treatment and diagnosis, and receive name recognition at this 2-days event. World-renowned speakers, the most recent techniques, developments, and the newest updates in women’s health, breast cancer, gynecological issues, pregnancy, Woman Psychology, women disorders are hallmarks of this conference.
Embassy Suites by Hilton Las Vegas
Las Vegas, USA
Go along with us for the advising occasion of the year. Participants can acquire CME through a wide assortment of auspicious learning sessions; exploit effective learning openings, for example, the Grad Students and New Professionals Only Sequence; Collaborate with directing associates from around the globe; pick up vocation experiences and additionally leads at the IOGR Summit 2017
Going to the IOGR Summit 2017 Conference is an interest in your vocation. There's no better approach to exhibit your dedication to the advising calling than to upgrade your aptitudes, improve your insight base, and expand your viewpoints - all in one extremely extraordinary place!
The sessions include Obstetrics, Gynecology, Reproductive Biology, Heredities in Obs and Gyn, Treatments in Pregnancy, Breast Disease, Prenatal Diagnosis, Midwifery, Gynecology & surgical procedure, Gynecologic cancers, Critical care in women health, Contraception, Health related Behaviours In Women, Infertility, Family planning, Reproductive Medicine, Nursing and Health care, Gynecological Endocrinology, Uro gynecology, Maternal-fetal medicine, Sexually transmitted Disease, Menopausal and geriatric gynecology
- 200+ Participation (70 Industry: 30 Academia)
- 5+ Keynote Speakers
- 50+ Plenary Speakers
- 10+ Exhibitors
- 12 Innovative Educational Sessions
- 5+ Workshops
- B2B Meetings
Allied Academics feels proud and pleasure to invite Research Scientists, Obstetricians, Gynaecologists, Professors, Students and Healthcare Diagnostics to attend the "International Obstetricians, Gynaecologists & Reproductive Biology" to be held atlas LAS VEGAS, USA during OCTOBER 5th& OCTOBER 6th,2017.
Allied Academics has been instrumental in Conducting International Meetings for 20 years and very excited to expand in Medical and health Care Fields. Allied Academics promotes peer reviewed healthcare information through meetings, scholarly journals, and training to leading academic, business and research institutes across the healthcare and life science industries.
Track 1: Gynecology & Obstetrics
Obstetrics and Gynecology is the medical specialty that deals with obstetrics and gynaecology. The postgraduate training program for both aspects is unified. This combined training prepares the practicing OB/GYN to be adept at the care of female reproductive organs' health and at the management of pregnancy.
Gynecology is the specialized field of medicine dealing with the health of a woman's genital system. The genital system consists of the reproductive organs, including the uterus (the womb; the organ in which a fetus develops), cervix (the opening between the uterus and the vagina), ovaries (organs that produce eggs and sex hormones), fallopian tubes (organs that carry eggs from the ovaries to the uterus), vagina (the muscular tube that extends from the uterus to outside the body), as well as their supporting structures.
Obstetrics is the field of study concentrated on pregnancy, childbirth, and the postpartum period. As a medical specialty, obstetrics is combined with gynaecology under the discipline known as obstetrics and gynaecology.
Track 2: Midwifery
Midwifery encompasses care of women during pregnancy, labour, and the postpartum period, as well as care of the new-born and the one who is a health science and health profession that deals with pregnancy, childbirth, and the postpartum period. It includes measures aimed at preventing health problems in pregnancy, the detection of abnormal conditions, the procurement of medical assistance when necessary, and the execution of emergency measures in the absence of medical help.
Midwifery, as known as obstetrics, is a health science and health profession that deals with pregnancy, childbirth, and the postpartum period (including care of the newborn), besides sexual and reproductive health of women throughout their lives. In many countries, midwifery is a medical profession (special for its independent and direct specialized education; should not be confused with a medical specialty, which depends on a previous general training).A professional in midwifery is known as a midwife.
Track 3: Urogynecology
Urogynecology is a sub-specialty of urology and Gynaecology and in some countries is also known as Female Pelvic Medicine and Reconstructive Surgery. An urogynecologist manages clinical problems associated with dysfunction of the pelvic floor and bladder. Pelvic floor disorders affect the bladder, reproductive organs, and bowels. It refers to the study and management of structural and functional changes of the urological system in female.
Track 4: Gynecological Endocrinology
The study of the maternal female hormone system includes the activities of the hypothalamus, pituitary, and ovaries from puberty through menopause. Women may suffering from multiple miscarriages, an inability to conceive, abnormally heavy or irregular periods, fibroids or discomfort related to menopause are considered to have gynaecological endocrinology disorders. Gynecological endocrinologists deal with a wide range of reproductive disorders as well.
Track 5: Gynecological Oncology
Gynecologic oncology is a specialized field of medicine that focuses on cancers of the female reproductive system, including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer. Cancer of the female reproductive tract also includes the endometrium, fallopian tubes, and vagina. The specialists in this do have extensive training in the diagnosis and treatment of these cancers.
Track 6: Genitourinary Medicine
Genitourinary is the branch of medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. Sexual health or genitourinary medicine (GUM) clinics offer a range of services, including: testing and treatment for sexually transmitted infections (STIs) advice and information about sexual health.
Track 7: Reproductive Medicine
The field cooperates with and overlaps mainly with reproductive endocrinology and infertility, sexual medicine and andrology, but also to some degree with gynecology, obstetrics, urology, genitourinary medicine, medical endocrinology, pediatric endocrinology, genetics, and psychiatry. Reproductive medicine is a branch of medicine that deals with prevention, diagnosis and management of reproductive problems; goals include improving or maintaining reproductive health and allowing people to have children at a time of their choosing. It is founded on knowledge of reproductive anatomy, physiology, and endocrinology, and incorporates relevant aspects of molecular biology, biochemistry and pathology. It addresses issues of sexual education, puberty, family planning, birth control, infertility, reproductive system disease (including sexually transmitted diseases) and sexual dysfunction. In women, reproductive medicine also covers menstruation, ovulation, pregnancy and menopause, as well as gynaecologic disorders that affect fertility.
Track 8: Prenatal Diagnosis
Prenatal diagnosis and prenatal screening are aspects of prenatal care that focus on detecting anatomic and physiologic problems with the zygote, embryo, or fetus as early as possible, either before gestation even starts (as in pre-implantation genetic diagnosis) or as early in gestation as practicable. It is a way for a doctor to determine, before birth, whether the fetus has a problem such as Down syndrome. The screening focuses on finding problems among a large population with affordable and noninvasive methods, whereas the diagnosis focuses on pursuing additional detailed information once a particular problem has been found, and can sometimes be more invasive. Screening can also be used for prenatal sex discernment. Amniocentesis and chorionic villus sampling (CVS) are tests that help find genetic disorders before birth. Common testing procedures include, ultrasonography including nuchal translucency ultrasound, serum biomarker testing, or genetic screening. In some cases, the tests are administered to determine if the fetus will be aborted, though physicians and patients also find it useful to diagnose high-risk pregnancies early so that delivery can be scheduled in a tertiary care hospital where the baby can receive appropriate care.
Track 9: Family Planning
Family planning is sometimes used as a synonym or euphemism for access to and the use of contraception. However, it often involves methods and practices in addition to contraception. Family planning is the practice of controlling the number of children in a family and the intervals between their births, particularly by means of artificial contraception or voluntary sterilization. Because "family" is included in the concept's name, consideration of a couple's desire to bear children, in the context of a family unit, is often considered primarily. Contemporary notions of family planning, however, tend to place a woman and her childbearing decisions at the center of the discussion, as notions of women's empowerment and reproductive autonomy have gained traction in many parts of the world. Family planning may involve consideration of the number of children a woman wishes to have, including the choice to have no children, as well as the age at which she wishes to have them. These matters are obviously influenced by external factors such as marital situation, career considerations, financial position, and any disabilities that may affect their ability to have children and raise them, besides many other considerations. If sexually active, family planning may involve the use of contraception and other techniques to control the timing of reproduction.
Track 11: Menopause
Menopause, also known as the climacteric, is the time in most women's lives when menstrual periods stop permanently, and they are no longer able to bear children. Menopause typically or usually occurs naturally, most often after age 45 or between 49 and 52 years of age. Medical professionals often define menopause as having occurred when a woman has not had any vaginal bleeding for a year. It may also be defined by a decrease in hormones (like estrogen and progesterone) production by the ovaries. In those who have had surgery to remove their uterus but they still have ovaries, menopause may be viewed to have occurred at the time of the surgery or when their hormone levels fell.
Track 12: Operative Gynaecology
Gynecological surgery or Operative Gynaecology
refers to surgery on the female reproductive system. Gynecological surgery is
usually performed by gynecologists. It includes procedures for benign
conditions, cancer, infertility, and incontinence. Gynecological surgery may
occasionally be performed for elective or cosmetic purposes.
Gynecological surgery or Operative Gynaecology refers to surgery on the female reproductive system. Gynecological surgery is usually performed by gynecologists. It includes procedures for benign conditions, cancer, infertility, and incontinence. Gynecological surgery may occasionally be performed for elective or cosmetic purposes.
Track 13: Infertility
Infertility is the inability of a person, animal or plant to reproduce by natural means. It is usually not the natural state of a healthy adult organism, except notably among certain eusocial species. In humans, infertility may describe a woman who is unable to conceive as well as being unable to carry a pregnancy to full term. There are many biological and other causes of infertility, including some that medical intervention can treat. It refers to an inability to conceive after having regular unprotected sex. Infertility can also refer to the biological inability of an individual to contribute to conception, or to a female who cannot carry a pregnancy to full term. In many countries infertility refers to a couple that has failed to conceive after 12 months of regular sexual intercourse without the use of contraception.
Track 14: Health Related Behaviours in Women
Women's health or wellbeing alludes to the soundness of ladies, which varies from that of men in numerous novel ways. Ladies' wellbeing is a case of populace wellbeing, where wellbeing is characterized by the World Health Organization as "a condition of finish physical, mental and social prosperity and not just the nonattendance of sickness or ailment". Regularly regarded as just ladies' conceptive wellbeing, many gatherings contend for a more extensive definition relating to the general soundness of ladies, better communicated as "The strength of ladies". These distinctions are further exacerbated in creating nations where ladies, whose wellbeing incorporates both their dangers and encounters, are further impeded.
Track 15: Maternal Supplements
Maternal supplements refer to the nutrient intake, and dietary planning that is undertaken before, during and after pregnancy. Nutrition of the fetus begins at conception. For this reason, the nutrition of the mother is important from before conception (probably several months before) as well as throughout pregnancy and breast feeding. An ever-increasing number of studies have shown that the nutrition of the mother will have an effect on the child, up to and including the risk for cancer, cardiovascular disease, hypertension and diabetes throughout life. An inadequate or excessive amount of some nutrients may cause malformations or medical problems in the fetus, and neurological disorders and handicaps are a risk that is run by mothers who are malnourished. A high number of babies worldwide are estimated to be born with lower than optimal weights at birth due to lack of proper nutrition. Even personal habits such as smoking, alcohol, caffeine, using certain medications and street drugs can negatively and irreversibly affect the development of the baby, which happens in the early stages of pregnancy.
Tracks 16: Abortion
Abortion, basically of two types: induced and spontaneous, is the ending of pregnancy by removing a fetus or embryo before it can survive outside the uterus. An abortion that occurs spontaneously is also known as a miscarriage. An abortion may be caused purposely and is then called an induced abortion, or less frequently, "induced miscarriage". The word abortion is often used to mean only induced abortions. A similar procedure after the fetus could potentially survive outside the womb is known as a "late termination of pregnancy".
Track 17: Ectopic Pregnancy
An ectopic pregnancy is a pregnancy that occurs outside the uterine cavity and usually in the fallopian tube. When the fertilized egg implants in the fallopian tube or somewhere else in the abdomen, it ends up with what’s called an ectopic pregnancy. It is also known as eccyesis or tubal pregnancy, possessing a complication of pregnancy in which the embryo attaches outside the uterus. Signs and symptoms classically include abdominal pain and vaginal bleeding. In these cases, the pregnancy can’t continue normally, and it requires emergency treatment.
Track 18: Enlargement of the Uterus
Besides pregnancy, there are several causes of an enlarged uterus. Two of the most common causes are uterine fibroids and adenomyosis. Uterine fibroids are common, non-cancerous tumors of the muscular wall of the uterus, affecting as many as eight in 10 women by the age of 50. The uterus sometimes may increase to double or triple its normal size with adenomyosis. It usually occurs after women have had children, and it disappears after menopause. Adenomyosis is a normally benign, but often painful condition where endometrial tissue, which normally lines the uterus, exists inside the uterus and grows into it’s the muscular walls.
Track 19: Fertility Preservation/ Contraception
Birth control, also known as contraception and fertility control or preservation, is a method or device used to prevent pregnancy. Birth control has been used since ancient times, but effective and safe methods of birth control only became available in the 20th century. Planning, making available and using birth control is called family planning. Some cultures limit or discourage access to birth control because they consider it to be morally, religiously, or politically undesirable. The most effective methods of birth control are sterilization by means of vasectomy in males and tubal ligation in females, intrauterine devices (IUDs), and implantable birth control.
Track 20: Folic Acid and Pregnancy
If a woman is pregnant or might become pregnant, it's critically important to get enough folic acid, the synthetic form of vitamin B9, also known as folate. Folic acid helps prevent neural tube defects (NTDs) – serious birth defects of the spinal cord (such as spina bifida) and the brain (such as anencephaly).
Track 21: In Vitro Fertilization
In vitro fertilization (or fertilization; IVF) is a type of assisted reproductive technology used for infertility treatment and gestational surrogacy in cases like: Blocked or damaged fallopian tubes; Male factor infertility including decreased sperm count or sperm motility. It is a process by which an egg is fertilized by sperm outside the body: in vitro ("in glass"). The process involves monitoring and stimulating a woman's ovulatory process, removing an ovum or ova (egg or eggs) from the woman's ovaries and letting sperm fertilize them in a liquid in a laboratory. The fertilised egg (zygote) is cultured for 2–6 days in a growth medium and is then transferred to the same or another woman's uterus, with the intention of establishing a successful pregnancy.
Track 22: Intrauterine insemination
Intrauterine insemination (IUI) is a fertility treatment that involves placing sperm inside a woman's uterus to facilitate fertilization. The goal of IUI is to increase the number of sperm that reach the fallopian tubes and subsequently increase the chance of fertilization. IUI is commonly used for unexplained infertility. It is also used for couples affected by mild endometriosis, problems with ovulation, mild male factor infertility and cervical factor infertility. Insemination is a reasonable initial treatment that should be utilized for a maximum of about 3 months in women who are ovulating (releasing eggs) on their own. It is reasonable to try IUI for longer in women with polycystic ovaries (PCOS) and lack of ovulation that have been given drugs to ovulate.
Track 23.: Male factor infertility
Misconceptions are very common in the world of infertility. One popular myth is that infertility is the woman's problem and that once that "problem" is fixed; the couple will be able to conceive. This could not be farther from the truth. In fact, in nearly 30% of all infertility cases, the cause is attributed to a factor in the male and in an additional 30% of cases the cause is attributed to both male and female factors. Less than a decade ago, treatment for a severe male factor was limited to inseminations or IVF using donor sperm. Today, exciting advances in male infertility have introduced innovative therapeutic options that offer men, including those with no sperm in their ejaculate due to genetic conditions, a greatly improved chance to conceive their own biological offspring. Male factor problems essentially fall into one of two categories: productive or obstructive. Problems with sperm production can stem from congenital (present at birth) problems with the testicle, hormone-related issues, varicose veins, environmental exposures, or cancer. In these cases, a detailed consultation with a reproductive endocrinologist or reproductive urologist can help pinpoint potential causes as well as facilitate treatment with the intent of improving a patient's numbers.
Track 24: Ovulation
Ovulation is the point at which a develop egg is discharged from the ovary, pushed down the fallopian tube, and is made accessible to be treated. Roughly consistently an egg will develop inside one of your ovaries. As it achieves development, the egg is discharged by the ovary where it enters the fallopian tube to advance towards sitting tight for sperm and the uterus. In other words Ovulation is the arrival of egg from the ovaries. In people, this occasion happens when the de Graff’s follicles crack and discharge the auxiliary oocyte ovarian cells. After ovulation, amid the luteal stage, the egg will be accessible to be prepared by sperm. What's more, the uterine coating (endometrium) is thickened to have the capacity to get a prepared egg. In the event that no origination happens, the uterine coating and in addition blood will be shed amid feminine cycle.
Track 27: Pelvic inflammatory disease
Pelvic provocative ailment or pelvic inflammatory disease (PID) is a disease of the upper piece of the female conceptive framework in particular the uterus, fallopian tubes, and ovaries, and within the pelvis. Often there might be no symptoms. Signs and indications, when present may incorporate lower stomach torment, vaginal release, fever, consuming with pee, torment with sex, or sporadic menstruation. Untreated PID can bring about long haul entanglements including barrenness, ectopic pregnancy, incessant pelvic torment, and cancer. The ailment is brought on by microscopic organisms that spread from the vagina and cervix. Infections by Neisseria gonorrhoea or Chlamydia trachomatis are available in 75 to 90 per cent of cases. Frequently numerous distinctive microbes are involved. Without treatment around 10 per cent of those with a chlamydial disease and 40 per cent of those with a gonorrhoea contamination will create PID. Risk components are like those of sexually transmitted diseases for the most part and incorporate a high number of sexual accomplices and medication utilize. Vaginal douching may likewise build the hazard. The determination is ordinarily in view of the showing signs and side effects. It is suggested that the ailment be considered in all ladies of childbearing age who have bring down stomach torment. A complete analysis of PID is made by discovering discharge including the fallopian tubes amid surgery. Ultrasound may likewise be valuable in diagnosis.
Track 26: Pituitary-gland problems
The pituitary organ is a pea-sized organ at the base of the cerebrum. The pituitary is the "ace control organ" - it produces numerous hormones that go all through the body, coordinating certain procedures or fortifying different organs to deliver different hormones & makes hormones that influence development and the elements of different organs in the body. The pituitary organ makes or stores a wide range of hormones. With pituitary issue, one frequently have excessively or too little of one of their hormones. Wounds can bring about pituitary issue, yet the most widely recognized cause is a pituitary tumour.
Track 27: Polycystic ovarian syndrome
Polycystic ovary syndrome (PCOS) is a hormonal condition that affects how your ovaries work. Usually, about five follicles start to mature during each menstrual cycle. At least one follicle releases a mature egg at ovulation. A polycystic ovary starts to mature at least twice as many follicles as normal, most of which enlarge and ripen but do not release an egg. It is estimated that between 22 and 33 per cent of women have polycystic ovaries. Some women go on to develop polycystic ovary syndrome (PCOS), which means they have other symptoms in addition to polycystic ovaries. PCOS happens when their hormonal system gets out of balance, making ovulation rare or irregular, and causing other changes in the body. Polycystic ovary syndrome is estimated to affect between five and 15 per cent of women of reproductive age, and it is thought to be more common in women of Asian descent. The exact cause of the problem is unknown but it's likely to be a combination of factors. Genetics are involved, as PCOS tends to run in families. Having higher than normal levels of the hormone insulin in your body is linked to PCOS.
Track 28: Pre-implantation genetic diagnosis
Pre-implantation hereditary analysis (PGD or PIGD) alludes to the hereditary profiling of incipient organisms preceding implantation (as a type of fetus profiling), and now and again even of oocytes before treatment. PGD is considered in a comparable manner to pre-birth analysis. At the point when used to screen for a particular hereditary malady, its primary preference is that it stays away from specific pregnancy end as the technique makes it exceedingly likely that the infant will be free of the infection under thought. PGD in this manner is a subordinate to helped conceptive innovation, and requires in vitro preparation (IVF) to get oocytes or incipient organisms for assessment.
Track 29: Reproductive Endocrinology
Reproductive Endocrinology and barrenness (REI) is a surgical subspecialty of obstetrics and gynaecology that trains doctors in conceptive medication tending to hormonal working in accordance with generation and the issue of fruitlessness. While most REI authorities principally concentrate on the treatment of fruitlessness, regenerative endocrinologists are prepared to likewise assess and treat hormonal dysfunctions in females and guys outside barrenness. Regenerative endocrinologists have claim to fame preparing in obstetrics and gynaecology (ob-gyn) before they experience sub-strength preparing (association) in REI.
Track 30: Thyroid problems
Thyroid disorders are conditions that affect the thyroid gland, a butterfly-shaped gland in the front of the neck. The thyroid has important roles to regulate numerous metabolic processes throughout the body. Different types of thyroid disorders affect either its structure or function. The thyroid gland is located below the Adam's apple wrapped around the trachea (windpipe). A thin area of tissue in the gland's middle, known as the isthmus, joins the two thyroid lobes on each side. The thyroid uses iodine to produce vital hormones. Thyroxine, also known as T4, is the primary hormone produced by the gland. After delivery via the bloodstream to the body's tissues, a small portion of the T4 released from the gland is converted to triiodothyronine (T3), which is the most active hormone. The function of the thyroid gland is regulated by a feedback mechanism involving the brain.
Track 31: Tubal factor infertility
Tubal factor infertility (TFI) is female infertility caused by diseases, obstructions, damage, scarring, congenital malformations or other factors which impede the descent of a fertilized or unfertilized ovum into the uterus through the Fallopian tubes and prevents a normal pregnancy and full term birth. Tubal factors cause 25-30% of infertility cases. Tubal factor is one complication of Chlamydia trachomatis infection in women.
Sexually transmitted Chlamydia and genital mycoplasma infections are preventable causes of infertility and negative pregnancy outcomes. When the infections progress and ascend, they can result in TFI. Infertility can have multiple possible causes and may not be recognized for years after gonorrhoea, Chlamydia or Mycoplasma infection has caused tubal damage, as the affected woman may not have attempted to become pregnant until years later. A blockage in the fallopian tubes will not allow the egg and sperm to meet. Tubal factor infertility accounts for about 25-30% of all cases of infertility. The condition includes cases of completely blocked fallopian tubes and cases where just one is blocked tube or scarring narrows the tubes.
Track 32: Uterine infections
Endometritis is a kind of uterine infections which is an inflammation or irritation of the lining of the uterus (the endometrium). It is not the same as endometriosis. Endometritis is caused by an infection in the uterus. It can be due to chlamydia, gonorrhoea, tuberculosis, or a mix of normal vaginal bacteria. It is more likely to occur after miscarriage or childbirth. It is also more common after a long labor or C-section. Endometritis is an inflammatory condition of the lining of the uterus, and it’s usually due to an infection. The uterus, or womb, is a major reproductive organ in women. It’s where the fetus develops during pregnancy.
Uterine Infection is usually not life-threatening, but it’s important to get it treated. It will generally go away when treated with antibiotics. Untreated infections can lead to complications with the reproductive organs, problems with fertility, and other general health problems.
World Market for
Gynecology, 2007-2017 provides a unique assessment of current developments and
prospective factors that will shape the global female health market over the
next decade. This unrivalled, in-depth market research study commissioned by
one of the top three multinational pharmaceutical companies presents a detailed
and comprehensive analysis of prescription products used in the diverse areas
of infertility, contraception, gynecological disorders, and menopause.
The market for gynecology is predicated on hormonal drugs that have recently been subject to controversy based on reports of associated increased risks of cardiovascular disease and cancer. The global market has suffered as a consequence due to cautious prescribing approaches for hormone replacement therapies. The market for gynecology is showing signs of a significant upward growth trend over the forecast period to 2017 and the next decade will be exciting, but companies will need to differentiate their products and consider the market forces that may affect product revenue and portfolios.
The World Market for Gynecology aims to provide an expert analysis of the prescription drug market for female health over the next decade based on current industrial insights, market factors and forces, and trend information. Study objectives include critical assessments of existing products, reviews of products in clinical development, therapy forecasting of product/portfolios to 2017, and market sector analytics by therapeutic category and discrete disorder.
The laparoscopic instruments market is projected to reach USD 11.68 Billion by 2021, growing at a CAGR of 8.9% during the forecast period of 2016 to 2021. Growth in the laparoscopic instruments market can be attributed to factors such as increasing investments in the laparoscopic instruments market, growing patient and physician preference for laparoscopic procedures as compared to open surgeries, rise in geriatric population, rise in prevalence of colorectal cancer and obesity which can be treated laparoscopically, and technological advances in the field of laparoscopic instruments. In the coming years, the laparoscopic instruments market is expected to witness the highest growth rate in the Asia-Pacific region. North America is expected to account for the largest share of the global laparoscopic instruments market in 2016. However, reduced Medicare payments to healthcare providers in the U.S., competition offered by robotic minimally invasive surgeries as an alternative to laparoscopic procedures, and dearth of trained physicians are likely to restrain the growth of the market during the forecast period.
The medical image analysis software market is expected to reach USD 3,135.3 Million by 2020 from USD 2,143.7 Million in 2015, at a CAGR of 7.9% from 2015 to 2020. Major factors driving the growth of this market include technological advancements, growing public- and private-sector investments, rapid growth in aging population, fusion of imaging technologies, growing applications of computer-aided diagnosis (CAD), rising incidences of chronic diseases, and increasing usage of imaging equipment. On the other hand, financial constraints, growing hacking-related risks associated with the use of medical equipment and software, and dearth of skilled professionals are the major factors restraining the growth of this market.
The global ultrasound market is expected to reach USD 6.86 Billion by 2020 from USD 5.25 Billion in 2015, at a CAGR of 5.5% from 2015 to 2020. Market growth can be attributed to the rising patient population base for chronic and lifestyle-related disorders (such as hypertension and vascular disorders) coupled with growing geriatric population; technological advancements; increasing public-private investments, funds, and grants; and growing market demand for minimally invasive disease diagnosis and treatment.
North America dominated the global market with a revenue share of 40.6% in 2014. High adoption rate of advanced technology and the presence of large market players in the region are some factors accounting for its large revenue share. The region is expected to maintain its dominance throughout the forecast period, mainly due to the growth in the number of new detected cases.
Government and healthcare agencies in North America are promoting routine check-ups to lower mortality rates associated with breast and cervical cancer patients since, early detection increases treatment success rates.
Asia Pacific is anticipated to witness lucrative growth during the forecast period. Growth in the inflow of patients owing to the rapidly booming medical tourism industry is expected to serve as the highest impact rendering driver.
Moreover, the presence of a large pool of skilled professionals, cheaper labor cost, and advance manufacturing facilities have resulted in the shifting of manufacturing facilities to China and India. As a result, the overall manufacturing costs of these devices have reduced. Therefore, manufacturers are now able to offer their products at lower cost.
Importance and Scope
Obstetrics deals with the care of pregnant women and the unborn child. Gynecology deals with the management of diseases that are specific to women. Many new techniques and procedures have been developed over years and improved the health of women and babies. The ultrasound devices have improved the care of the baby in the womb. It has been evolving in both molecular and clinical level with many researches. The research in Obstetrics and Gynecology lead to the discovery of maternal and fetal medicine, reproductive medicine, urogynaecology, gynecological oncology and reproductive health care.
Scope of the Report:
Commissioned by a market leader in Women’s and Sexual Health, this report uniquely provides a comprehensive analysis of current and pipeline gynecology products, which is not available elsewhere in the market literature; Provides a concise overview of the conditions and diseases related to gynecology including aetiology, epidemiology, and management; Complete description of existing products to include reviews of product characteristics, side effects, and sales performance; Extensive information on new gynecological drugs in the pipeline, including product characteristics, technologies, research status, and the results of clinical trials; Market analysis of the US and international markets for gynecological prescription products with therapy area and sales forecasts to 2017; Analysis of market dynamics for infertility, contraception, menstrual and gynecological disorders, and menopause; Product-focused appraisals and discussions for market potential and growth; Benchmark analytics for current research themes and future therapy areas; Evaluation of the key drivers and predictors of growth and innovation in gynecology; In-depth assessment of the commercial and drug development opportunities in the field. Reports on the status of existing and pipeline gynecology prescription products to 2017; Highlights the drug development strategies that are being employed by companies to sustain leadership; Provides a comprehensive description of gynecological and obstetric drugs currently on the market; Describes the pipelines and biological targets being pursued by a host of companies, both small and large; Assists in analyzing discovery programs of competitors and aids decision-making for in-house research and development; Provides critical information on how companies are reformulating hormonal drugs to solve market, clinical, and regulatory barriers; Provides market trend data of best- and least-performing gynecology products; Identifies niche markets where there is an unmet need for gynecological and obstetric therapeutics; Provides forecasts of products, therapy areas, and drug classes to 2017; Shows estimation of the global market for gynecology to include both hormonal and non-hormonal products.